PMID- 27661776 OWN - NLM STAT- MEDLINE DCOM- 20170515 LR - 20191210 IS - 1097-4652 (Electronic) IS - 0021-9541 (Linking) VI - 232 IP - 6 DP - 2017 Jun TI - Hypoglycemia Enhances Epithelial-Mesenchymal Transition and Invasiveness, and Restrains the Warburg Phenotype, in Hypoxic HeLa Cell Cultures and Microspheroids. PG - 1346-1359 LID - 10.1002/jcp.25617 [doi] AB - The accelerated growth of solid tumors leads to episodes of both hypoxia and hypoglycemia (HH) affecting their intermediary metabolism, signal transduction, and transcriptional activity. A previous study showed that normoxia (20% O(2) ) plus 24 h hypoglycemia (2.5 mM glucose) increased glycolytic flux whereas oxidative phosphorylation (OxPhos) was unchanged versus normoglycemia in HeLa cells. However, the simultaneous effect of HH on energy metabolism has not been yet examined. Therefore, the effect of hypoxia (0.1-1% O(2) ) plus hypoglycemia on the energy metabolism of HeLa cells was analyzed by evaluating protein content and activity, along with fluxes of both glycolysis and OxPhos. Under hypoxia, in which cell growth ceased and OxPhos enzyme activities, DeltaPsim and flux were depressed, hypoglycemia did not stimulate glycolytic flux despite increasing H-RAS, p-AMPK, GLUT1, GLUT3, and HKI levels, and further decreasing mitochondrial enzyme content. The impaired mitochondrial function in HH cells correlated with mitophagy activation. The depressed OxPhos and unchanged glycolysis pattern was also observed in quiescent cells from mature multicellular tumor spheroids, suggesting that these inner cell layers are similarly subjected to HH. The principal ATP supplier was glycolysis for HH 2D monolayer and 3D quiescent spheroid cells. Accordingly, the glycolytic inhibitors iodoacetate and gossypol were more effective than mitochondrial inhibitors in decreasing HH-cancer cell viability. Under HH, stem cell-, angiogenic-, and EMT-biomarkers, as well as glycoprotein-P content and invasiveness, were also enhanced. These observations indicate that HH cancer cells develop an attenuated Warburg and pronounced EMT- and invasive-phenotype. J. Cell. Physiol. 232: 1346-1359, 2017. (c) 2016 Wiley Periodicals, Inc. CI - (c) 2016 Wiley Periodicals, Inc. FAU - Marin-Hernandez, Alvaro AU - Marin-Hernandez A AD - Departamento de Bioquimica, Instituto Nacional de Cardiologia, Mexico, Mexico. FAU - Gallardo-Perez, Juan Carlos AU - Gallardo-Perez JC FAU - Hernandez-Resendiz, Ileana AU - Hernandez-Resendiz I FAU - Del Mazo-Monsalvo, Isis AU - Del Mazo-Monsalvo I FAU - Robledo-Cadena, Diana Xochiquetzal AU - Robledo-Cadena DX FAU - Moreno-Sanchez, Rafael AU - Moreno-Sanchez R FAU - Rodriguez-Enriquez, Sara AU - Rodriguez-Enriquez S AD - Departamento de Bioquimica, Instituto Nacional de Cardiologia, Mexico, Mexico. LA - eng PT - Journal Article DEP - 20160930 PL - United States TA - J Cell Physiol JT - Journal of cellular physiology JID - 0050222 RN - 0 (Antineoplastic Agents) RN - 8L70Q75FXE (Adenosine Triphosphate) RN - IY9XDZ35W2 (Glucose) RN - S88TT14065 (Oxygen) SB - IM MH - Adenosine Triphosphate/pharmacology MH - Antineoplastic Agents/pharmacology MH - Cell Hypoxia/drug effects MH - Cell Proliferation/drug effects MH - Cell Survival/drug effects MH - Energy Metabolism/drug effects MH - *Epithelial-Mesenchymal Transition/drug effects MH - Glucose/pharmacology MH - *Glycolysis/drug effects MH - HeLa Cells MH - Humans MH - Hypoglycemia/*pathology MH - Inhibitory Concentration 50 MH - MCF-7 Cells MH - Mitochondria/drug effects/metabolism MH - Mitophagy/drug effects MH - Neoplasm Invasiveness MH - Oxygen/pharmacology MH - Phenotype MH - Spheroids, Cellular/drug effects/metabolism/*pathology EDAT- 2016/09/24 06:00 MHDA- 2017/05/16 06:00 CRDT- 2016/09/24 06:00 PHST- 2016/07/14 00:00 [received] PHST- 2016/09/22 00:00 [accepted] PHST- 2016/09/24 06:00 [pubmed] PHST- 2017/05/16 06:00 [medline] PHST- 2016/09/24 06:00 [entrez] AID - 10.1002/jcp.25617 [doi] PST - ppublish SO - J Cell Physiol. 2017 Jun;232(6):1346-1359. doi: 10.1002/jcp.25617. Epub 2016 Sep 30.